Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals Revenue

In the year 2024, Ligand Pharmaceuticals had annual revenue of $167.13M with 27.28% growth. Ligand Pharmaceuticals had revenue of $42.81M in the quarter ending December 31, 2024, with 52.35% growth.

• Revenue (ttm): $167.13M
• Revenue Growth: +27.28%
• P/S Ratio: 12.00
• Revenue / Employee: $2,457,838
• Employees: 68
• Market Cap: 2.06B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	167.13M	35.82M	27.28%
Dec 31, 2023	131.31M	-64.93M	-33.09%
Dec 31, 2022	196.25M	-45.30M	-18.75%
Dec 31, 2021	241.54M	77.98M	47.68%
Dec 31, 2020	163.56M	43.28M	35.98%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.